Article info

Download PDFPDF

Protocol
Adoptive immunotherapy with natural killer cells from peripheral blood CD34+ stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study

Authors

  1. Correspondence to Dr Hideki Ohdan; hohdan{at}hiroshima-u.ac.jp
View Full Text

Citation

Ohira M, Kobayashi T, Tanaka Y, et al
Adoptive immunotherapy with natural killer cells from peripheral blood CD34+ stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study

Publication history

  • Received May 9, 2022
  • Accepted September 30, 2022
  • First published November 21, 2022.
Online issue publication 
December 29, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.